Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed S Mahmood

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of the American College of Cardiology|October 29, 2021
Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell TherapyAdam Goldman, Elad Maor, David Bomze, et al.
Cancer Medicine|December 23, 2018
Case-control study of heart rate abnormalities across the breast cancer survivorship continuumJohn D Groarke, Syed S Mahmood, David Payne, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 14, 2020
Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancerJohn D Groarke, David L Payne, Brian Claggett, et al.
Radiology. Cardiothoracic Imaging|March 29, 2021
Imaging Utilization and Outcomes in Vulnerable Populations during COVID-19 in New York CityDennis Toy, Syed S Mahmood, Jessica Rotman, et al.
Journal of the American College of Cardiology|March 24, 2018
Myocarditis in Patients Treated With Immune Checkpoint InhibitorsSyed S Mahmood, Michael G Fradley, Justine V Cohen, et al.
British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.
Journal of the American College of Cardiology|December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
JAMA|August 8, 2023
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical TrialTomas G Neilan, Thiago Quinaglia, Takeshi Onoue, et al.
Circulation|June 17, 2020
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated MyocarditisLili Zhang, Daniel A Zlotoff, Magid Awadalla, et al.
European Heart Journal|March 20, 2023
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipientsSyed S Mahmood, Peter A Riedell, Stephanie Feldman, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of the American College of Cardiology|October 29, 2021
Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell TherapyAdam Goldman, Elad Maor, David Bomze, et al.
Cancer Medicine|December 23, 2018
Case-control study of heart rate abnormalities across the breast cancer survivorship continuumJohn D Groarke, Syed S Mahmood, David Payne, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 14, 2020
Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancerJohn D Groarke, David L Payne, Brian Claggett, et al.
Radiology. Cardiothoracic Imaging|March 29, 2021
Imaging Utilization and Outcomes in Vulnerable Populations during COVID-19 in New York CityDennis Toy, Syed S Mahmood, Jessica Rotman, et al.
Journal of the American College of Cardiology|March 24, 2018
Myocarditis in Patients Treated With Immune Checkpoint InhibitorsSyed S Mahmood, Michael G Fradley, Justine V Cohen, et al.
British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.
Journal of the American College of Cardiology|December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
JAMA|August 8, 2023
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical TrialTomas G Neilan, Thiago Quinaglia, Takeshi Onoue, et al.
Circulation|June 17, 2020
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated MyocarditisLili Zhang, Daniel A Zlotoff, Magid Awadalla, et al.
European Heart Journal|March 20, 2023
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipientsSyed S Mahmood, Peter A Riedell, Stephanie Feldman, et al.
Pageof 4